Marc Labelle

7.9k total citations · 1 hit paper
40 papers, 6.0k citations indexed

About

Marc Labelle is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Marc Labelle has authored 40 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 18 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Marc Labelle's work include Chemical Synthesis and Analysis (9 papers), Inflammatory mediators and NSAID effects (9 papers) and Synthesis and Biological Evaluation (7 papers). Marc Labelle is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Inflammatory mediators and NSAID effects (9 papers) and Synthesis and Biological Evaluation (7 papers). Marc Labelle collaborates with scholars based in Canada, United States and United Kingdom. Marc Labelle's co-authors include Yves Gareau, Michel Gallant, Donald W. Nicholson, Nancy A. Thornberry, John P. Vaillancourt, Violeta Yu, Mark E. Smulson, Ting-Ting Yamin, Patrick R. Griffin and Yuri Lazebnik and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Marc Labelle

39 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1995 3.6k citations Donald W. Nicholson, Ambereen Ali et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Labelle Canada	23	3.6k	919	873	819	790	40	6.0k
Yves Gareau Canada	26	3.5k 1.0×	864 0.9×	1.1k 1.2×	803 1.0×	805 1.0×	49	6.1k
Michel Gallant Canada	20	3.5k 1.0×	633 0.7×	618 0.7×	782 1.0×	791 1.0×	38	5.5k
Ronald L. Magolda United States	29	3.0k 0.8×	635 0.7×	687 0.8×	950 1.2×	728 0.9×	69	5.6k
Tatsuya Tamaoki Japan	31	4.3k 1.2×	714 0.8×	749 0.9×	926 1.1×	593 0.8×	66	6.6k
Makoto Morimoto Japan	22	3.3k 0.9×	670 0.7×	843 1.0×	664 0.8×	540 0.7×	71	5.1k
Abdul H. Fauq United States	45	3.0k 0.8×	610 0.7×	780 0.9×	749 0.9×	809 1.0×	121	5.7k
Sabine Grösch Germany	42	2.8k 0.8×	1.3k 1.5×	459 0.5×	726 0.9×	505 0.6×	84	5.2k
Keith B. Glaser United States	35	2.8k 0.8×	842 0.9×	789 0.9×	774 0.9×	657 0.8×	108	4.9k
Ho Jeong Kwon South Korea	44	5.0k 1.4×	773 0.8×	591 0.7×	948 1.2×	562 0.7×	204	7.3k
Dolores Pérez‐Sala Spain	45	3.8k 1.1×	937 1.0×	351 0.4×	475 0.6×	670 0.8×	144	6.7k

Countries citing papers authored by Marc Labelle

Since Specialization

Citations

This map shows the geographic impact of Marc Labelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Labelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Labelle more than expected).

Fields of papers citing papers by Marc Labelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Labelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Labelle. The network helps show where Marc Labelle may publish in the future.

Co-authorship network of co-authors of Marc Labelle

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Labelle. A scholar is included among the top collaborators of Marc Labelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Labelle. Marc Labelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Labelle, Marc. (2013). An Operational Model to Evaluate Assessment and Management Procedures for the North Pacific Swordfish Fishery. University of North Texas Digital Library (University of North Texas).

Jiao, Xian‐Yun, David J. Kopecky, Derek E. Piper, et al.. (2012). Discovery and optimization of a series of liver X receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(18). 5966–5970. 16 indexed citations

Kopecky, David J., Marc Labelle, Derek E. Piper, et al.. (2012). Discovery of a new binding mode for a series of liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 22(7). 2407–2410. 10 indexed citations

Tu, Hua, Jay P. Powers, Jinsong Liu, et al.. (2008). Distinctive molecular inhibition mechanisms for selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1. Bioorganic & Medicinal Chemistry. 16(19). 8922–8931. 30 indexed citations

Belley, Michel, Chi Chung Chan, Yves Gareau, et al.. (2006). Comparison between two classes of selective EP3 antagonists and their biological activities. Bioorganic & Medicinal Chemistry Letters. 16(21). 5639–5642. 27 indexed citations

Pan, Weitao, Hu Liu, Yong‐Jiang Xu, et al.. (2005). Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases. Bioorganic & Medicinal Chemistry Letters. 15(24). 5474–5477. 18 indexed citations

Liu, Hu, et al.. (2005). Improved synthesis of functionalized 5,6-dihydro-pyrimido[4,5-b][1,4]oxazepines. Tetrahedron Letters. 46(44). 7523–7526. 7 indexed citations

Belley, Michel, Michel Gallant, Bruno Roy, et al.. (2004). Structure–activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP3 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 527–530. 24 indexed citations

Gallant, Michel, Michel Belley, Marie‐Claude Carrière, et al.. (2003). Structure–activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptor. Bioorganic & Medicinal Chemistry Letters. 13(21). 3813–3816. 21 indexed citations

10.

Gallant, Michel, Marie‐Claude Carrière, Anne Châteauneuf, et al.. (2002). Structure–Activity Relationship of Biaryl Acylsulfonamide Analogues on the Human EP3 Prostanoid Receptor. Bioorganic & Medicinal Chemistry Letters. 12(18). 2583–2586. 37 indexed citations

11.

Machwate, M., Satoru Harada, Chih‐Tai Leu, et al.. (2001). Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2. Molecular Pharmacology. 60(1). 36–41. 17 indexed citations

12.

Machwate, M., Satoru Harada, Chih‐Tai Leu, et al.. (2001). Prostaglandin Receptor EP₄ Mediates the Bone Anabolic Effects of PGE₂. Molecular Pharmacology. 60(1). 36–41. 144 indexed citations

13.

Jûteau, Hélène, Yves Gareau, Marc Labelle, et al.. (2001). Structure–activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor. Bioorganic & Medicinal Chemistry. 9(8). 1977–1984. 111 indexed citations

14.

Abramovitz, Mark, Mohammed Adam, Yves Boie, et al.. (2000). The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1483(2). 285–293. 473 indexed citations

15.

Ruel, Réjean, Mark Abramovitz, Claude Godbout, et al.. (1999). New class of biphenylene dibenzazocinones as potent ligands for the human EP1 prostanoid receptor. Bioorganic & Medicinal Chemistry Letters. 9(18). 2699–2704. 18 indexed citations

16.

Larsen, Robert D., Edward G. Corley, Anthony O. King, et al.. (1996). Practical Route to a New Class of LTD₄ Receptor Antagonists. The Journal of Organic Chemistry. 61(10). 3398–3405. 202 indexed citations

17.

Rotonda, J., Donald W. Nicholson, Michel Gallant, et al.. (1996). The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Structural Biology. 3(7). 619–625. 356 indexed citations

18.

Lau, Cheuk K., C. DUFRESNE, Yves Gareau, et al.. (1995). Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists. Bioorganic & Medicinal Chemistry Letters. 5(15). 1615–1620. 27 indexed citations

19.

Nicholson, Donald W., Ambereen Ali, Nancy A. Thornberry, et al.. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376(6535). 37–43. 3612 indexed citations breakdown →

20.

Gravel, Denis & Marc Labelle. (1985). The γ-alkylation of cyclic β-ketoesters via their enamine derivatives. Canadian Journal of Chemistry. 63(7). 1874–1883. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact